Sigilon Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/07/2023 | Q2 2023 | -$4.71 | -$3.00 | 1.71 | $5.90 M | |
| 05/09/2023 | Q1 2023 | -$0.23 | -$0.23 | 0 | $4.86 M | |
| 03/14/2023 | Q4 2022 | $0.38 | -$0.17 | -0.55 | $2.64 M | |
| 11/10/2022 | Q3 2022 | -$5.59 | -$0.28 | 5.31 | $4.25 M | |
| 08/04/2022 | Q2 2022 | -$5.98 | -$0.45 | 5.53 | $2.88 M | |
| 05/12/2022 | Q1 2022 | -$3.90 | -$5.57 | -1.67 | $3.17 M | |
| 03/14/2022 | Q4 2021 | -$5.98 | -$0.55 | 5.43 | $1.99 M | |
| 11/10/2021 | Q3 2021 | -$8.97 | -$8.17 | 0.8 | $1.95 M | |
| 08/10/2021 | Q2 2021 | -$7.54 | -$8.42 | -0.88 | $2.70 M | |
| 05/10/2021 | Q1 2021 | -$7.28 | -$7.83 | -0.55 | $2.96 M | |
| 03/18/2021 | Q4 2020 | $1.37 | -$1.15 | -2.52 | $3.76 M | |
| 09/29/2020 | Q3 2020 | -$5.96 | $4.20 M | |||
| 06/29/2020 | Q2 2020 | -$8.33 | $1.95 M | |||
| 03/30/2020 | Q1 2020 | -$7.87 | $3.47 M | |||
| 12/30/2019 | Q4 2019 | $0.00 | $3.10 M |
Sigilon Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Sigilon Therapeutics, Inc.'s earnings date?
Sigilon Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off last year's report dates.
-
Did Sigilon Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Sigilon Therapeutics, Inc. (:SGTX) reported $-2.89 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.71 by $1.82.
-
How can I listen to Sigilon Therapeutics, Inc.'s earnings conference call?
The conference call for Sigilon Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Sigilon Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Sigilon Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Sigilon Therapeutics, Inc. generate each year?
Sigilon Therapeutics, Inc. (:SGTX) has a recorded annual revenue of $12.94 M.
-
How much profit does Sigilon Therapeutics, Inc. generate each year?
Sigilon Therapeutics, Inc. (:SGTX) has a recorded net income of $12.94 M. Sigilon Therapeutics, Inc. has generated $-1.34 earnings per share over the last four quarters.
-
What is Sigilon Therapeutics, Inc.'s price-to-earnings ratio?
Sigilon Therapeutics, Inc. (:SGTX) has a price-to-earnings ratio of -16.76 and price/earnings-to-growth ratio is 0.07.
